Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial (Q84874289)
Jump to navigation
Jump to search
scientific article published on 01 September 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial |
scientific article published on 01 September 2011 |
Statements
Adalimumab or cyclosporine as monotherapy and in combination in severe psoriatic arthritis: results from a prospective 12-month nonrandomized unblinded clinical trial (English)
Petros P Sfikakis
George N Karanikolas
Eftyhia-Maria Koukli
Aikaterini Katsalira
Aikaterini Arida
Dimitrios Petrou
Eleni Komninou
Kalliopi Fragiadaki
Anna Zacharioudaki
Ioannis Lasithiotakis
Eirini Giavri
George Vaiopoulos
1 September 2011